Hongyu Wang, M.D., Vice President of Peking University Shougang Hospital, Professor and Chief Physician of Department of Cardiology and Vascular Medicine, Director of the Vascular Health Research Center of Peking University Health Science Center(VHRC-PKUHSC), and Director of the Peking University Chinical Research Institute Heart and Vascular Research Center (PURI-HVRC). He firstly established the early vascular lesion detection technology and published the first guideline in 2005 and renewed this guideline in 2011. The early vascular lesion detection technology was approved by the Ministry of Health of the People`s Republic of China to be promoted to the whole of China in 2004. The early vascular lesion detection technology was spread and popularized as national program named the China Heart and Vascular Health Promotion Project (CHVHPP) in hundreds of hospitals in more than 20 provinces from 2004 to 2021. He founded and organized the first international vascular medicine congress, the Chinese International Congress of Vascular Medicine (CCVM), in 2004, and established the first vascular medicine center in China in 2010. He has hosted large multicenter clinical trials and cohort studies named BEST, EndoFIND, and BVHS, on the relationship between vascular health management and cardiovascular diseases outcomes in 2011, 2019, and 2020. Recently, he has put forward a new vascular healthy classification method named the Beijing Vascular Health Stratification (BVHS).
Peking University Shougang Hospital
Beijing, China